Doctors, economists, lawmakers, and civil society groups fighting the WTO waiver are funded by the pharmaceutical lobby.JUST BEFORE GOING live on Al Jazeera last week, Achal Prabhala, an activist for equitable access to medicine, performed a quick internet search on his sparring partner in a debate on the proposal to share vaccine technology with low-income countries.It didn’t take long before Prabhala found that his opponent, an academic who favors pharmaceutical monopoly rights, leads an institute at Duke University funded by Pfizer and AstraZeneca. He pointed this fact out to the producers on air.The apparent conflict of interest is hardly a rare occurrence.The InterceptLee Fang - DRUG INDUSTRY MONEY QUIETLY BACKS MEDIA VOICES AGAINST SHARING VACCINE PATENTS
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Matias Vernengo writes Elon Musk (& Vivek Ramaswamy) on hardship, because he knows so much about it
Lars Pålsson Syll writes Klas Eklunds ‘Vår ekonomi’ — lärobok med stora brister
New Economics Foundation writes We need more than a tax on the super rich to deliver climate and economic justice
Robert Vienneau writes Profits Not Explained By Merit, Increased Risk, Increased Ability To Compete, Etc.
Doctors, economists, lawmakers, and civil society groups fighting the WTO waiver are funded by the pharmaceutical lobby.
JUST BEFORE GOING live on Al Jazeera last week, Achal Prabhala, an activist for equitable access to medicine, performed a quick internet search on his sparring partner in a debate on the proposal to share vaccine technology with low-income countries.
It didn’t take long before Prabhala found that his opponent, an academic who favors pharmaceutical monopoly rights, leads an institute at Duke University funded by Pfizer and AstraZeneca. He pointed this fact out to the producers on air.
The apparent conflict of interest is hardly a rare occurrence.
The Intercept
Lee Fang - DRUG INDUSTRY MONEY QUIETLY BACKS MEDIA VOICES AGAINST SHARING VACCINE PATENTS